List view / Grid view
7 January 2019 | By European Pharmaceutical Review
Major factors driving the growth of the global APIs market are thought to be the increasing incidence of chronic diseases, growing importance of generics, and the increasing uptake of biopharmaceuticals...
7 January 2019 | By European Pharmaceutical Review
The results of a long-term study on the use of ADHD medication has advised that they are unlikely to result in heart damage, or cardiac difficulties...
4 January 2019 | By Iqra Farooq (European Pharmaceutical Review)
The FDA has clarified what it can and cannot do in light of the ongoing US government shutdown meaning a lapse in funding during the period...
4 January 2019 | By Nikki Withers
Innovators should be able to get products to the UK market as quickly and simply as possible, according to the Medicines and Healthcare products Regulatory Agency...
4 January 2019 | By Iqra Farooq (European Pharmaceutical Review)
The MHRA have announced another sartan-containing drug product over fears that it is contaminated with the carcinogen N‑nitrosodiethylamine...
3 January 2019 | By Iqra Farooq (European Pharmaceutical Review)
Deloitte has found a sharp decline in the returns on investment from top pharmaceutical companies, with returns at almost half of what they were in 2010...
3 January 2019 | By Iqra Farooq (European Pharmaceutical Review)
A clinical trial to analyse breath for volatile organic compounds to detect different types of cancer has been launched by Cancer Research UK...
2 January 2019 | By European Pharmaceutical Review
A study has found that when compared with other drugs, canagliflozin may not be associated with fractures in patients with diabetes...
2 January 2019 | By Iqra Farooq (European Pharmaceutical Review)
Minority unerrepresentation in clinical trials for drugs to treat MS has led to doctors being unable to make informed decisions when prescribing...
20 December 2018 | By Kolb
Standard excipients can be sourced from various suppliers, but what if you need to customise an excipient to suit your needs?
14 December 2018 | By European Pharmaceutical Review
Researchers have identified markers of pediatric acute lymphoblastic leukaemia to predict early relapses by testing levels of nucleotide excision repair...
14 December 2018 | By European Pharmaceutical Review
It is paramount that manufacturers and their suppliers ensure that the quality of compounded drugs are high, by preventing risks of contamination...
13 December 2018 | By European Pharmaceutical Review
The FDA has provided guidance on data integrity and compliance; two areas extremely important for pharmaceutical businesses and manufacturers to adhere to...
13 December 2018 | By European Pharmaceutical Review
A blood test could transform the way doctors treat people affected by cystic fibrosis, helping to personalise treatments to individual people...
12 December 2018 | By European Pharmaceutical Review
A sprayable gel containing calcium carbonate nanoparticles with antibodies targeted to block CD47, could be the future of drug delivery for cancer...
Follow: